Minireview: Roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology

Endocrinology

Volumn 152, Issue 4, 2011, Pages 1199-1208

  Pisarska, Margareta D ^a,b   Barlow, Gillian ^a   Kuo, Fang Ting ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG;

CARCINOGENESIS; CYTOLOGY; FEMALE; GENE MUTATION; GRANULOSA CELL; HUMAN; NONHUMAN; OVARY DEVELOPMENT; OVARY DISEASE; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; SEX DETERMINATION; SHORT SURVEY;

ANIMALS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELLS; HUMANS; MALE; OVARIAN FOLLICLE;

EID: 79953169851     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1041     Document Type: Short Survey

References (118)

1. Weigel D, Jurgens G, Kuttner F, Seifert E, Jackle H 1989 The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57:645-658
2. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS 2003 Fox's in development and disease. Trends Genet 19:339-344 (Pubitemid 36694617)
3. Mahlapuu M, Ormestad M, Enerback S, Carlsson P 2001 The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development 128:155-166 (Pubitemid 32124142)
4. Nakae J, Kitamura T, Kitamura Y, Biggs 3rd WH, Arden KC, Accili D 2003 The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119-129 (Pubitemid 36105338)
5. Brissette JL, Li J, Kamimura J, Lee D, Dotto GP 1996 The product of the mouse nude locus, Whn, regulates the balance between epithelial cell growth and differentiation. Genes Dev 10:2212-2221 (Pubitemid 26303876)
6. Dottori M, Gross MK, Labosky P, Goulding M 2001 The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate. Development 128:4127-4138 (Pubitemid 33077027)
7. Parry P, Wei Y, Evans G 1994 Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer 11:79-84 (Pubitemid 24300181)
8. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG 2002 FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62:4773-4780
9. Radisavljevic Z 2003 Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells. Cancer 97:1358-1363 (Pubitemid 36237325)
10. Kaufmann E, Knochel W 1996 Five years on the wings of fork head. Mech Dev 57:3-20 (Pubitemid 26197454)
11. Carlsson P, Mahlapuu M 2002 Forkhead transcription factors: key players in development and metabolism. Dev Biol 250:1-23
12. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G 2001 The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166 (Pubitemid 32157442)
13. Zlotogora J, Sagi M, Cohen T 1983 The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35:1020-1027 (Pubitemid 13008598)
14. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG 1998 Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704 (Pubitemid 28299519)
15. Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, Veitia RA 2002 Evolution and expression of FOXL2. J Med Genet 39:916-921
16. Pisarska MD, Bae J, Klein C, Hsueh AJ 2004 Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145:3424-3433 (Pubitemid 38830015)
17. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M 2004 The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942 (Pubitemid 38263207)
18. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G 2004 Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171-1181 (Pubitemid 38786999)
19. Fraser IS, Shearman RP, Smith A, Russell P 1988 An association among blepharophimosis, resistant ovary syndrome, and true premature menopause. Fertil Steril 50:747-751
20. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, Forabosco A, Pilia G, Schlessinger D 2005 Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053-2062 (Pubitemid 41418041)
21. Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B 2008 Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 17:2949-2955
22. Chassot AA, Gregoire EP, Magliano M, Lavery R, Chaboissier MC 2008 Genetics of ovarian differentiation: Rspo1, a major player. Sex Dev 2:219-227
23. Sekido R, Lovell-Badge R 2008 Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453:930-934 (Pubitemid 351832560)
24. Bishop CE, Whitworth DJ, Qin Y, Agoulnik AI, Agoulnik IU, Harrison WR, Behringer RR, Overbeek PA 2000 A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet 26:490-494
25. Vidal VP, Chaboissier MC, de Rooij DG, Schedl A 2001 Sox9 induces testis development in XX transgenic mice. Nat Genet 28:216-217 (Pubitemid 32626021)
26. Hersmus R, Kalfa N, de Leeuw B, Stoop H, Oosterhuis JW, de Krijger R, Wolffenbuttel KP, Drop SL, Veitia RA, Fellous M, Jaubert F, Looijenga LH 2008 FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol 215:31-38 (Pubitemid 351619873)
27. Garcia-Ortiz JE, Pelosi E, Omari S, Nedorezov T, Piao Y, Karmazin J, Uda M, Cao A, Cole SW, Forabosco A, Schlessinger D, Ottolenghi C 2009 Foxl2 functions in sex determination and histogenesis throughout mouse ovary development. BMC Dev Biol 9:36
28. Li H, Bishop KM, O'Leary DD 2006 Potential target genes of EMX2 include Odz/Ten-M and other gene families with implications for cortical patterning. Mol Cell Neurosci 33:136-149 (Pubitemid 44415488)
29. Worzfeld T, Puschel AW, Offermanns S, Kuner R 2004 Plexin-B family members demonstrate non-redundant expression patterns in the developing mouse nervous system: an anatomical basis for morphogenetic effects of Sema4D during development. Eur J Neurosci 19:2622-2632 (Pubitemid 38746379)
30. Hintsch G, Zurlinden A, Meskenaite V, Steuble M, Fink-Widmer K, Kinter J, Sonderegger P 2002 The calsyntenins-a family of postsynaptic membrane proteins with distinct neuronal expression patterns. Mol Cell Neurosci 21:393-409 (Pubitemid 36062727)
31. Zhang Q, Wang J, Fan S, Wang L, Cao L, Tang K, Peng C, Li Z, Li W, Gan K, Liu Z, Li X, Shen S, Li G 2005 Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily. FEBS Lett 579:3674-3682 (Pubitemid 40897708)
32. Byskov AG, Guoliang X, Andersen CY 1997 The cortex-medulla oocyte growth pattern is organized during fetal life: an in-vitro study of the mouse ovary. Mol Hum Reprod 3:795-800 (Pubitemid 127509614)
33. Cvoro A, Tzagarakis-Foster C, Tatomer D, Paruthiyil S, Fox MS, Leitman DC 2006 Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 21:555-564 (Pubitemid 43228010)
34. Hara A, Inoue Y, Nakagawa M, Naganeo F, Sawada H 1988 Purification and characterization of NADP+-dependent 3 alpha-hydroxysteroid dehydrogenase from mouse liver cytosol. J Biochem 103:1027-1034
35. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R 1991 Male development of chromosomally female mice transgenic for Sry. Nature 351:117-121 (Pubitemid 21896542)
36. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM 2000 Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet 25:453-457 (Pubitemid 32983442)
37. Sirianni R, Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V, Rainey WE 2002 Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J Endocrinol 174:R13-R17
38. Bakke M, Zhao L, Hanley NA, Parker KL 2001 SF-1: a critical mediator of steroidogenesis. Mol Cell Endocrinol 171:5-7 (Pubitemid 32098191)
39. Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, Treier AC, Klugmann C, Klasen C, Holter NI, Riethmacher D, Schutz G, Cooney AJ, Lovell-Badge R, Treier M 2009 Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139:1130-1142
40. Oshima Y, Uno Y, Matsuda Y, Kobayashi T, Nakamura M 2008 Molecular cloning and gene expression of Foxl2 in the frog Rana rugosa. Gen Comp Endocrinol 159:170-177
41. Nakamoto M, Wang DS, Suzuki A, Matsuda M, Nagahama Y, Shibata N 2007 Dax1 suppresses P450arom expression in medaka ovarian follicles. Mol Reprod Dev 74:1239-1246 (Pubitemid 350195107)
42. Wang DS, Kobayashi T, Zhou LY, Paul-Prasanth B, Ijiri S, Sakai F, Okubo K, Morohashi K, Nagahama Y 2007 Foxl2 up-regulates aromatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein/steroidogenic factor 1. Mol Endocrinol 21:712-725
43. Yamaguchi T, Yamaguchi S, Hirai T, Kitano T 2007 Follicle-stimulating hormone signaling and Foxl2 are involved in transcriptional regulation of aromatase gene during gonadal sex differentiation in Japanese flounder, Paralichthys olivaceus. Biochem Biophys Res Commun 359:935-940 (Pubitemid 46946907)
44. Pailhoux E, Vigier B, Chaffaux S, Servel N, Taourit S, Furet JP, Fellous M, Grosclaude F, Cribiu EP, Cotinot C, Vaiman D 2001 A 11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet 29:453-458 (Pubitemid 34326697)
45. Baroiller JF, D'Cotta H, Bezault E, Wessels S, Hoerstgen-Schwark G 2009 Tilapia sex determination: where temperature and genetics meet. Comp Biochem Physiol A Mol Integr Physiol 153:30-38
46. Pannetier M, Servel N, Cocquet J, Besnard N, Cotinot C, Pailhoux E 2003 Expression studies of the PIS-regulated genes suggest different mechanisms of sex determination within mammals. Cytogenet Genome Res 101:199-205 (Pubitemid 38064898)
47. Hanna-Rose W, Hansen U 1996 Active repression mechanisms of eukaryotic transcription repressors. Trends Genet 12:229-234 (Pubitemid 26163012)
48. Sullivan SA, Akers L, Moody SA 2001 foxD5a, a Xenopus winged helix gene, maintains an immature neural ectoderm via transcriptional repression that is dependent on the C-terminal domain. Dev Biol 232:439-457 (Pubitemid 32337106)
49. Sutton J, Costa R, Klug M, Field L, Xu D, Largaespada DA, Fletcher CF, Jenkins NA, Copeland NG, Klemsz M, Hromas R 1996 Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem 271:23126-23133 (Pubitemid 26314748)
50. Bourguignon C, Li J, Papalopulu N 1998 XBF-1, a winged helix transcription factor with dual activity, has a role in positioning neurogenesis in Xenopus competent ectoderm. Development 125:4889-4900 (Pubitemid 29026770)
51. Xuan S, Baptista CA, Balas G, Tao W, Soares VC, Lai E 1995 Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron 14:1141-1152
52. Hromas R, Ye H, Spinella M, Dmitrovsky E, Xu D, Costa RH 1999 Genesis, a Winged Helix transcriptional repressor, has embryonic expression limited to the neural crest, and stimulates proliferation in vitro in a neural development model. Cell Tissue Res 297:371-382 (Pubitemid 29410527)
53. Bentsi-Barnes IK, Kuo FT, Barlow GM, Pisarska MD 2009 Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2. Fertil Steril 94:353-356
54. Clark BJ, Wells J, King SR, Stocco DM 1994 The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 269:28314-28322
55. Lin D, Sugawara T, Strauss 3rd JF, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828-1831
56. Stocco DM 2001 StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63:193-213 (Pubitemid 32304316)
57. Pollack SE, Furth EE, Kallen CB, Arakane F, Kiriakidou M, Kozarsky KF, Strauss 3rd JF 1997 Localization of the steroidogenic acute regulatory protein in human tissues. J Clin Endocrinol Metabol 82:4243-4251. (Pubitemid 27525548)
58. Baron D, Cocquet J, Xia X, Fellous M, Guiguen Y, Veitia RA 2004 An evolutionary and functional analysis of FoxL2 in rainbow trout gonad differentiation. J Mol Endocrinol 33:705-715 (Pubitemid 40057564)
59. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 61:353-357 (Pubitemid 29344748)
60. Skinner MK 2005 Regulation of primordial follicle assembly and development. Hum Reprod Update 11:461-471 (Pubitemid 41418801)
61. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474 (Pubitemid 26414665)
62. Moons DS, Jirawatnotai S, Tsutsui T, Franks R, Parlow AF, Hales DB, Gibori G, Fazleabas AT, Kiyokawa H 2002 Intact follicular maturation and defective luteal function in mice deficient for cyclin-dependent kinase-4. Endocrinology 143:647-654 (Pubitemid 34107220)
63. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, Saito M, Nomura M, Mukasa C, Okabe T, Goto K, Takayanagi R, Kashimura Y, Haji M, Nawata H 2001 Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142:437-445 (Pubitemid 32183706)
64. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA 2007 Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci USA 104:3330-3335 (Pubitemid 46364159)
65. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD 1988 Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 85:5259-5263
66. Wolf SF, Sieburth D, Sypek J 1994 Interleukin 12: a key modulator of immune function. Stem cells (Dayton, Ohio) 12:154-168 (Pubitemid 24105531)
67. Srinivas S, Dai J, Eskdale J, Gallagher GE, Megjugorac NJ, Gallagher G 2008 Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 125:492-502
68. Son EW, Rhee DK, Pyo S 2006 Gamma-irradiation-induced intercellular adhesion molecule-1 (ICAM-1) expression is associated with catalase: activation of Ap-1 and JNK. J Toxicol Environ Health A 69:2137-2155 (Pubitemid 44639603)
69. Ahrens T, Pertz O, Haussinger D, Fauser C, Schulthess T, Engel J 2002 Analysis of heterophilic and homophilic interactions of cadherins using the c-Jun/c-Fos dimerization domains. J Biol Chem 277:19455-19460 (Pubitemid 34967455)
70. D'Sa-Eipper C, Chinnadurai G 1998 Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene 16:3105-3114 (Pubitemid 28318781)
71. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF 1998 IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281:998-1001 (Pubitemid 28399251)
72. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK 1997 Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208 (Pubitemid 27456387)
73. Kim SY, Weiss J, Tong M, Laronda MM, Lee EJ, Jameson JL 2009 Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha. Endocrinology 150:5085-5093
74. Yazawa T, Inaoka Y, Okada R, Mizutani T, Yamazaki Y, Usami Y, Kuribayashi M, Orisaka M, Umezawa A, Miyamoto K 2010 PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1. Mol Endocrinol 24:485-496
75. Park M, Shin E, Won M, Kim JH, Go H, Kim HL, Ko JJ, Lee K, Bae J 2005 FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Mol Endocrinol 24:1024-1036
76. Johnson ES 2004 Protein modification by SUMO. Annu Rev Biochem 73:355-382 (Pubitemid 39050373)
77. Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH 2003 SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem 278:31043-31048 (Pubitemid 36994618)
78. Ronen-Fuhrmann T, Timberg R, King SR, Hales KH, Hales DB, Stocco DM, Orly J 1998 Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 139:303-315
79. Benayoun BA, Batista F, Auer J, Dipietromaria A, L'Hote D, De Baere E, Veitia RA 2009 Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. Hum Mol Genet 18:632-644
80. Kuo FT, Bentsi-Barnes IK, Barlow GM, Bae J, Pisarska MD 2009 Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cell Signal 21:1935-1944
81. Marongiu M, Deiana M, Meloni A, Marcia L, Puddu A, Cao A, Schlessinger D, Crisponi L 2010 The forkhead transcription factor Foxl2 is sumoylated in bothhumanand mouse: sumoylation affects its stability, localization, and activity. PloS One 5:e9477
82. Pisarska MD, Kuo FT, Bentsi-Barnes IK, Khan S, Barlow GM 2010 LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity. Am J Physiol Endocrinol Metab 299:E101-E109
83. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T 1999 Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21:182-186 (Pubitemid 29070363)
84. Ou Q, Mouillet JF, Yan X, Dorn C, Crawford PA, Sadovsky Y 2001 The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Mol Endocrinol 15:69-79 (Pubitemid 32156042)
85. Lee K, Pisarska MD, Ko JJ, Kang Y, Yoon S, Ryou SM, Cha KY, Bae J 2005 Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. Biochem Biophys Res Commun 336:876-881 (Pubitemid 41338350)
86. Pelusi C, Ikeda Y, Zubair M, Parker KL 2008 Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells. Biol Reprod 79:1074-1083
87. Blount AL, Schmidt K, Justice NJ, Vale WW, Fischer WH, Bilezikjian LM 2009 FoxL2 and Smad3 coordinately regulate follistatin gene transcription. J Biol Chem 284:7631-7645
88. Bilezikjian LM, Blount AL, Leal AM, Donaldson CJ, Fischer WH, Vale WW 2004 Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 225:29-36 (Pubitemid 39297052)
89. DePaolo LV, Mercado M, Guo Y, Ling N 1993 Increased follistatin (activin-binding protein) gene expression in rat anterior pituitary tissue after ovariectomy may be mediated by pituitary activin. Endocrinology 132:2221-2228 (Pubitemid 23133275)
90. Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH, Vale W 1991 Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128:1682-1684
91. Burger LL, Haisenleder DJ, Dalkin AC, Marshall JC 2004 Regulation of gonadotropin subunit gene transcription. J Mol Endocrinol 33:559-584 (Pubitemid 40057556)
92. Corpuz PS, Lindaman LL, Mellon PL, Coss D 2010 FoxL2 Is required for activin induction of the mouse and human follicle-stimulating hormone beta-subunit genes. Mol Endocrinol 24:1037-1051
93. Meduri G, Bachelot A, Duflos C, Bstandig B, Poirot C, Genestie C, Veitia R, De Baere E, Touraine P 2010 FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case Report. Hum Reprod 25:235-243
94. De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K, Gillerot Y, Mortier G, Meire F, Van Maldergem L, Courtens W, Hjalgrim H, Huang S, Liebaers I, Van Regemorter N, Touraine P, Praphanphoj V, Verloes A, Udar N, Yellore V, Chalukya M, Yelchits S, De Paepe A, Kuttenn F, Fellous M, Veitia R, Messiaen L 2001 Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis- epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 10:1591-1600 (Pubitemid 32734311)
95. Ramirez-Castro JL, Pineda-Trujillo N, Valencia AV, Muneton CM, Botero O, Trujillo O, Vasquez G, Mora BE, Durango N, Bedoya G, Ruiz-Linares A 2002 Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am J Med Genet 113:47-51 (Pubitemid 35192586)
96. De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L 2003 FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet 72:478-487 (Pubitemid 36194256)
97. Pisarska M, Bentsi-Barnes I, Barlow G, Kuo F 2010 FOXL2 mutations associated with premature ovarian failure (POF) likely dimerize with wild type FOXL2, leading to altered regulation of genes associated with granulosa cell differentiation. The Endocrine Society's 92nd Annual Meeting, San Diego, CA
98. Beysen D, Moumne L, Veitia R, Peters H, Leroy BP, De Paepe A, De Baere E 2008 Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation. Hum Mol Genet 17:2030-2038 (Pubitemid 351865851)
99. Schumer ST, Cannistra SA 2003 Granulosa cell tumor of the ovary. J Clin Oncol 21:1180-1189 (Pubitemid 46594151)
100. Colombo N, Parma G, Zanagnolo V, Insinga A 2007 Management of ovarian stromal cell tumors. J Clin Oncol 25:2944-2951 (Pubitemid 47123159)
101. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D, Economopoulos T, Andreadis C 2008 Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res 28:1421-1427 (Pubitemid 351578890)
102. Fuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG 1998 No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metabol 83:274-279 (Pubitemid 28498350)
103. Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ 2002 FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod 8:426-433 (Pubitemid 34567920)
104. Graves PE, Surwit EA, Davis JR, Stouffer RL 1985 Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators. Am J Obstet Gynecol 153:877-882 (Pubitemid 16174274)
105. Stouffer RL, Grodin MS, Davis JR, Surwit EA 1984 Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. J Clin Endocrinol Metabol 59:441-446 (Pubitemid 14031787)
106. Rey RA, Lhomme C, Marcillac I, Lahlou N, Duvillard P, Josso N, Bidart JM 1996 Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 174:958-965 (Pubitemid 26114717)
107. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK 1997 Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol 64:64-69 (Pubitemid 27026958)
108. Jobling T, Mamers P, Healy DL, MacLachlan V, Burger HG, Quinn M, Rome R, Day AJ 1994 A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 55:285-289 (Pubitemid 24366640)
109. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW 1989 Inhibin as a marker for granulosa-cell tumors. N Engl J Med 321:790-793 (Pubitemid 19237426)
110. Kaye SB, Davies E 1986 Cyclophosphamide, adriamycin, and cisplatinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol 24:261-264 (Pubitemid 16060029)
111. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG 2009 Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360:2719-2729
112. Kim MS, Hur SY, Yoo NJ, Lee SH 2010 Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol 221:147-152
113. Kim T, Sung CO, Song SY, Bae DS, Choi YL 2010 FOXL2 mutation in granulosa-cell tumours of the ovary. Histopathology 56: 408-410
114. Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, Salamanca C, Maines-Bandiera S, Cooke SL, Leung P, Brenton JD, Gilks CB, Monahan J, Huntsman DG 2009 The specificity of the FOXL2 c. 402C>G somatic mutation: a survey of solid tumors. PloS One 4:e7988
115. Jamieson S, Butzow R, Andersson N, Alexiadis M, Unkila-Kallio L, Heikinheimo M, Fuller PJ, Anttonen M 2010 The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Mod Pathol 23:1477-1485
116. Benayoun BA, Caburet S, Dipietromaria A, Georges A, D'Haene B, Pandaranayaka PJ, L'Hote D, Todeschini AL, Krishnaswamy S, Fellous M, De Baere E, Veitia RA 2010 Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c. 402C>G). PloS One 5:e8789
117. Kalfa N, Fellous M, Boizet-Bonhoure B, Patte C, Duvillard P, Pienkowski C, Jaubert F, Ecochard A, Sultan C 2008 Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol 180:1810-1813
118. Lamba P, Fortin J, Tran S, Wang Y, Bernard DJ 2009 A novel role for the forkhead transcription factor FOXL2 in activin A-regulated follicle-stimulating hormone beta subunit transcription. Mol Endocrinol 23:1001-1013